Trials / Unknown
UnknownNCT04640350
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Through the parameters of liver stiffness and spleen stiffness obtained by combi-elastography technique, summarize and analyze the warning index of esophagogastric variceal bleeding in patients with cirrhosis, so as to provide a new and valuable technique for clinical diagnosis.
Detailed description
Firstly,the combi-elastography technique developed by HITACHI uses the method of multi-index and multi-parameter to evaluate the liver stiffness and spleen stiffness comprehensively. And then,this prospective study is designed to follow up patients with cirrhosis for a period of 12 months, summarize and analyze the warning index of bleeding in patients with cirrhosis,so as to provide a new and valuable technique for clinical diagnosis.
Conditions
Timeline
- Start date
- 2020-12-31
- Primary completion
- 2022-12-31
- Completion
- 2023-05-31
- First posted
- 2020-11-23
- Last updated
- 2021-01-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04640350. Inclusion in this directory is not an endorsement.